MedTrace Logo

Safe and Easy Access Technique for the First Trocar in Laparoscopic Obesity Surgery

NCT03015935 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-01-16

No results posted yet for this study

Summary

Laparoscopic surgery has become very popular and standard in many indications after advancements of technique. Various methods have been used in first entry to the abdomen. Safety, wound size, to be not time-consuming, low cost, learning curve and efficacy are important. Several techniques, instruments, and approaches to minimize the risk of injury (the bowel, bladder, major abdominal vessels, and an anterior abdominal wall vessel) have been introduced.

There is no consensus yet on an optimal method has yet emerged.

The investigators aimed to evaluate efficacy of entry methods that ensures safe insertion of the first trocar at any site of the abdomen.

To evaluate the efficacy of entry technique, the investigators used cohort of patients who will be planned to laparoscopic obesity surgery.

Two methods are commonly used in surgical literature and in our center.

The investigators have been used visible optical-entry technique in some patients for first entry and Veress technique in some other patients.

For this purpose, the investigators designed an observational study.

Conditions

  • Obesity, Morbid

Interventions

PROCEDURE

visual-assisted entry

First trocar entry will be performed with visual-assisted trocar

PROCEDURE

Veress entry

First trocar entry will be performed with Veress

Sponsors & Collaborators

  • Umraniye Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Fatih Basak · Umraniye Education and Research Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2018-01-31
Completion
2018-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03015935 on ClinicalTrials.gov